Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Myelodysplastic Syndromes | 22 | 2024 | 1394 | 3.990 |
Why?
|
Leukemia, Myeloid, Acute | 25 | 2024 | 3612 | 2.810 |
Why?
|
Hematopoietic Stem Cell Transplantation | 15 | 2024 | 5672 | 1.340 |
Why?
|
Hematopoiesis | 9 | 2021 | 2049 | 1.240 |
Why?
|
Hematologic Neoplasms | 9 | 2021 | 1896 | 1.110 |
Why?
|
Mutation | 33 | 2024 | 30016 | 1.010 |
Why?
|
Sulfonamides | 7 | 2024 | 1977 | 0.970 |
Why?
|
Leukemia | 5 | 2024 | 1520 | 0.890 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2022 | 186 | 0.760 |
Why?
|
Bone Marrow Diseases | 3 | 2021 | 233 | 0.710 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 2 | 2022 | 305 | 0.700 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2018 | 94 | 0.690 |
Why?
|
Dioxygenases | 2 | 2021 | 344 | 0.680 |
Why?
|
Transplantation Conditioning | 7 | 2024 | 1590 | 0.680 |
Why?
|
Telomerase | 2 | 2021 | 744 | 0.650 |
Why?
|
Anemia, Aplastic | 2 | 2018 | 230 | 0.620 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2022 | 682 | 0.590 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 1608 | 0.550 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2024 | 2917 | 0.540 |
Why?
|
Pancytopenia | 1 | 2017 | 102 | 0.530 |
Why?
|
Myeloproliferative Disorders | 5 | 2024 | 611 | 0.500 |
Why?
|
Disease Susceptibility | 3 | 2023 | 1788 | 0.500 |
Why?
|
Telomere | 2 | 2020 | 940 | 0.500 |
Why?
|
Clone Cells | 3 | 2017 | 1657 | 0.490 |
Why?
|
Transplantation, Homologous | 10 | 2024 | 4804 | 0.490 |
Why?
|
Neoplasms, Second Primary | 3 | 2024 | 1051 | 0.480 |
Why?
|
Hematopoietic Stem Cells | 6 | 2020 | 3394 | 0.450 |
Why?
|
Neoplasm, Residual | 2 | 2022 | 1008 | 0.440 |
Why?
|
Hematologic Diseases | 1 | 2017 | 496 | 0.430 |
Why?
|
Bone Marrow Neoplasms | 1 | 2013 | 101 | 0.410 |
Why?
|
Stem Cell Transplantation | 1 | 2020 | 1600 | 0.400 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 2012 | 120 | 0.390 |
Why?
|
DNA Methylation | 3 | 2024 | 4391 | 0.390 |
Why?
|
B-Lymphocyte Subsets | 5 | 2019 | 238 | 0.380 |
Why?
|
Survival Rate | 6 | 2024 | 12719 | 0.350 |
Why?
|
Leukemia, Erythroblastic, Acute | 2 | 2021 | 176 | 0.340 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2024 | 11736 | 0.330 |
Why?
|
Embryonic Stem Cells | 3 | 2011 | 1262 | 0.300 |
Why?
|
DNA-Binding Proteins | 4 | 2024 | 9586 | 0.290 |
Why?
|
Cell Cycle Proteins | 4 | 2024 | 3447 | 0.290 |
Why?
|
Repressor Proteins | 5 | 2022 | 2985 | 0.290 |
Why?
|
Bone Marrow | 6 | 2023 | 2909 | 0.280 |
Why?
|
Prognosis | 12 | 2024 | 29600 | 0.280 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2012 | 988 | 0.270 |
Why?
|
Genetic Variation | 1 | 2021 | 6561 | 0.260 |
Why?
|
Graft vs Host Disease | 3 | 2024 | 3028 | 0.260 |
Why?
|
Humans | 72 | 2024 | 760617 | 0.260 |
Why?
|
Wnt Proteins | 2 | 2008 | 718 | 0.260 |
Why?
|
Lymphoma, B-Cell | 1 | 2012 | 938 | 0.250 |
Why?
|
Cytarabine | 3 | 2024 | 697 | 0.250 |
Why?
|
Epigenesis, Genetic | 5 | 2022 | 3794 | 0.240 |
Why?
|
Postoperative Hemorrhage | 1 | 2008 | 414 | 0.240 |
Why?
|
ras Proteins | 2 | 2022 | 1054 | 0.240 |
Why?
|
Chromosomal Proteins, Non-Histone | 2 | 2024 | 725 | 0.240 |
Why?
|
Alleles | 5 | 2022 | 6861 | 0.240 |
Why?
|
fms-Like Tyrosine Kinase 3 | 4 | 2023 | 495 | 0.230 |
Why?
|
Thrombocytosis | 1 | 2024 | 88 | 0.230 |
Why?
|
Blood Loss, Surgical | 1 | 2008 | 636 | 0.230 |
Why?
|
Remission Induction | 2 | 2024 | 2391 | 0.230 |
Why?
|
Recombinant Fusion Proteins | 2 | 2012 | 3730 | 0.230 |
Why?
|
Thrombocythemia, Essential | 1 | 2024 | 113 | 0.220 |
Why?
|
Gene Duplication | 2 | 2022 | 314 | 0.220 |
Why?
|
Mesoderm | 1 | 2006 | 674 | 0.220 |
Why?
|
Hand | 1 | 2008 | 902 | 0.210 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2024 | 251 | 0.210 |
Why?
|
Anthracyclines | 2 | 2023 | 285 | 0.210 |
Why?
|
Hemorrhage | 3 | 2024 | 3418 | 0.200 |
Why?
|
RNA Splice Sites | 1 | 2023 | 210 | 0.200 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2011 | 3608 | 0.200 |
Why?
|
DNA Damage | 2 | 2023 | 2446 | 0.200 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2008 | 1133 | 0.200 |
Why?
|
Tandem Repeat Sequences | 2 | 2020 | 180 | 0.200 |
Why?
|
Disease-Free Survival | 3 | 2021 | 6807 | 0.190 |
Why?
|
Thrombocytopenia | 2 | 2023 | 1182 | 0.190 |
Why?
|
Erythropoiesis | 2 | 2016 | 684 | 0.190 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 226 | 0.190 |
Why?
|
Genetic Predisposition to Disease | 4 | 2022 | 17878 | 0.190 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2020 | 3634 | 0.190 |
Why?
|
Stem Cells | 3 | 2020 | 3516 | 0.180 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2021 | 85 | 0.180 |
Why?
|
Hydroxyurea | 1 | 2022 | 282 | 0.180 |
Why?
|
Cell Differentiation | 10 | 2019 | 11514 | 0.180 |
Why?
|
Cardiovascular System | 1 | 2008 | 834 | 0.180 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1670 | 0.180 |
Why?
|
DNA Mutational Analysis | 4 | 2017 | 4110 | 0.180 |
Why?
|
Adult | 22 | 2024 | 220969 | 0.180 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2024 | 687 | 0.170 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2024 | 610 | 0.170 |
Why?
|
Dyskeratosis Congenita | 1 | 2020 | 73 | 0.170 |
Why?
|
Mutation, Missense | 3 | 2019 | 2570 | 0.170 |
Why?
|
Nuclear Proteins | 4 | 2024 | 5789 | 0.160 |
Why?
|
Melphalan | 1 | 2020 | 420 | 0.160 |
Why?
|
Young Adult | 9 | 2024 | 59179 | 0.160 |
Why?
|
Mycoses | 1 | 2022 | 386 | 0.160 |
Why?
|
Point Mutation | 2 | 2015 | 1595 | 0.150 |
Why?
|
Middle Aged | 19 | 2024 | 220584 | 0.150 |
Why?
|
Candidiasis | 1 | 2021 | 365 | 0.150 |
Why?
|
Janus Kinase 2 | 2 | 2022 | 560 | 0.150 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2024 | 937 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 3 | 2022 | 4512 | 0.150 |
Why?
|
Azepines | 1 | 2019 | 329 | 0.150 |
Why?
|
Mesenchymal Stem Cells | 1 | 2008 | 1642 | 0.150 |
Why?
|
Ribosomes | 1 | 2021 | 500 | 0.140 |
Why?
|
Recurrence | 4 | 2022 | 8426 | 0.140 |
Why?
|
Adolescent | 8 | 2024 | 88234 | 0.140 |
Why?
|
Neoplasms | 5 | 2023 | 22131 | 0.140 |
Why?
|
Leukopenia | 1 | 2017 | 213 | 0.140 |
Why?
|
Germ-Line Mutation | 2 | 2022 | 1852 | 0.130 |
Why?
|
Aged | 16 | 2024 | 169042 | 0.130 |
Why?
|
Epithelial Cells | 1 | 2008 | 3672 | 0.130 |
Why?
|
B-Lymphocytes | 2 | 2006 | 4745 | 0.130 |
Why?
|
Calgranulin A | 1 | 2016 | 80 | 0.130 |
Why?
|
Calgranulin B | 1 | 2016 | 86 | 0.130 |
Why?
|
Anemia, Dyserythropoietic, Congenital | 1 | 2015 | 15 | 0.120 |
Why?
|
Leukemia, Mast-Cell | 1 | 2015 | 13 | 0.120 |
Why?
|
Phosphoproteins | 3 | 2024 | 2446 | 0.120 |
Why?
|
Ribonucleoprotein, U2 Small Nuclear | 1 | 2014 | 20 | 0.120 |
Why?
|
Interleukin-2 | 1 | 2022 | 1887 | 0.120 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2020 | 709 | 0.120 |
Why?
|
RNA | 2 | 2022 | 2713 | 0.120 |
Why?
|
Anemia, Macrocytic | 1 | 2015 | 53 | 0.120 |
Why?
|
Selection, Genetic | 1 | 2019 | 868 | 0.120 |
Why?
|
5-Aminolevulinate Synthetase | 1 | 2015 | 64 | 0.120 |
Why?
|
RNA Splicing | 2 | 2023 | 898 | 0.120 |
Why?
|
Male | 19 | 2024 | 360358 | 0.120 |
Why?
|
Cancer Vaccines | 1 | 2022 | 1037 | 0.120 |
Why?
|
Genes, p53 | 1 | 2017 | 712 | 0.120 |
Why?
|
Female | 21 | 2024 | 392148 | 0.120 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 184 | 0.120 |
Why?
|
Haploinsufficiency | 1 | 2016 | 336 | 0.110 |
Why?
|
HLA Antigens | 1 | 2019 | 1329 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2015 | 315 | 0.110 |
Why?
|
Ribosomal Proteins | 1 | 2016 | 370 | 0.110 |
Why?
|
Mice | 19 | 2023 | 81368 | 0.110 |
Why?
|
Mastocytosis, Systemic | 1 | 2015 | 103 | 0.110 |
Why?
|
Animals | 21 | 2023 | 168201 | 0.110 |
Why?
|
Anemia, Sickle Cell | 1 | 2021 | 1059 | 0.110 |
Why?
|
Medical Informatics | 1 | 2020 | 732 | 0.110 |
Why?
|
Anticoagulants | 1 | 2008 | 4785 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2023 | 2118 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 360 | 0.100 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 2012 | 111 | 0.100 |
Why?
|
Models, Immunological | 2 | 2005 | 512 | 0.100 |
Why?
|
Blood | 1 | 2014 | 596 | 0.100 |
Why?
|
Gene Deletion | 1 | 2019 | 2661 | 0.100 |
Why?
|
Germ Layers | 1 | 2011 | 72 | 0.090 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2015 | 386 | 0.090 |
Why?
|
Genetic Markers | 1 | 2017 | 2601 | 0.090 |
Why?
|
Infant | 3 | 2021 | 36152 | 0.090 |
Why?
|
Cell Dedifferentiation | 1 | 2011 | 122 | 0.090 |
Why?
|
Receptors, Complement | 3 | 2006 | 253 | 0.090 |
Why?
|
Leukemia, Myeloid | 1 | 2013 | 693 | 0.090 |
Why?
|
Chromatin | 1 | 2022 | 2955 | 0.090 |
Why?
|
Myeloid Cells | 1 | 2015 | 823 | 0.090 |
Why?
|
Hospitals | 1 | 2023 | 3877 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1551 | 0.090 |
Why?
|
Child, Preschool | 3 | 2021 | 42188 | 0.080 |
Why?
|
Transplantation, Autologous | 3 | 2024 | 2112 | 0.080 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2011 | 737 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2017 | 1372 | 0.080 |
Why?
|
Genomic Instability | 1 | 2013 | 709 | 0.080 |
Why?
|
Phenotype | 2 | 2020 | 16571 | 0.080 |
Why?
|
Hodgkin Disease | 1 | 2017 | 1378 | 0.080 |
Why?
|
B-Cell Activating Factor | 2 | 2006 | 115 | 0.080 |
Why?
|
Cytokines | 2 | 2021 | 7373 | 0.080 |
Why?
|
Child | 4 | 2021 | 80079 | 0.080 |
Why?
|
Membrane Glycoproteins | 3 | 2006 | 3688 | 0.080 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1850 | 0.080 |
Why?
|
Spleen | 2 | 2006 | 2286 | 0.080 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2011 | 546 | 0.070 |
Why?
|
Mast Cells | 1 | 2015 | 1392 | 0.070 |
Why?
|
Histones | 2 | 2019 | 2577 | 0.070 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12966 | 0.070 |
Why?
|
Pyrimidines | 1 | 2019 | 3027 | 0.070 |
Why?
|
Receptors, IgE | 2 | 2006 | 375 | 0.070 |
Why?
|
Tissue Donors | 1 | 2017 | 2331 | 0.070 |
Why?
|
Transcription Factors | 4 | 2022 | 12116 | 0.070 |
Why?
|
Retrospective Studies | 7 | 2024 | 80566 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2024 | 58894 | 0.070 |
Why?
|
Signal Transduction | 3 | 2022 | 23416 | 0.070 |
Why?
|
Chronic Disease | 1 | 2021 | 9311 | 0.070 |
Why?
|
L-Selectin | 1 | 2006 | 211 | 0.070 |
Why?
|
Anemia | 1 | 2016 | 1504 | 0.070 |
Why?
|
Graft Survival | 1 | 2017 | 3820 | 0.070 |
Why?
|
Antifungal Agents | 2 | 2022 | 753 | 0.070 |
Why?
|
Doxycycline | 1 | 2008 | 344 | 0.070 |
Why?
|
Mice, Knockout | 5 | 2019 | 14389 | 0.070 |
Why?
|
Sequence Analysis, DNA | 1 | 2017 | 4739 | 0.070 |
Why?
|
RNA-Binding Proteins | 1 | 2015 | 1890 | 0.060 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 1745 | 0.060 |
Why?
|
Disease Progression | 1 | 2022 | 13495 | 0.060 |
Why?
|
MicroRNAs | 2 | 2011 | 3805 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 2 | 2004 | 581 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2821 | 0.060 |
Why?
|
Genes, Dominant | 2 | 2019 | 851 | 0.060 |
Why?
|
Genomics | 4 | 2023 | 5822 | 0.060 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15251 | 0.060 |
Why?
|
Antineoplastic Agents | 2 | 2021 | 13635 | 0.060 |
Why?
|
Survival Analysis | 1 | 2017 | 10073 | 0.060 |
Why?
|
Chondroitin Sulfate Proteoglycans | 1 | 2024 | 141 | 0.060 |
Why?
|
Cell Survival | 3 | 2016 | 5780 | 0.060 |
Why?
|
Daunorubicin | 1 | 2024 | 157 | 0.060 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2008 | 463 | 0.050 |
Why?
|
Flow Cytometry | 4 | 2016 | 5863 | 0.050 |
Why?
|
Interleukin-4 | 1 | 2006 | 1146 | 0.050 |
Why?
|
Cells, Cultured | 5 | 2015 | 18937 | 0.050 |
Why?
|
Blotting, Western | 3 | 2016 | 5034 | 0.050 |
Why?
|
Ligands | 2 | 2006 | 3268 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2004 | 445 | 0.050 |
Why?
|
Azacitidine | 1 | 2024 | 335 | 0.050 |
Why?
|
Platelet Count | 1 | 2024 | 780 | 0.050 |
Why?
|
Proteins | 1 | 2017 | 6030 | 0.050 |
Why?
|
Vaccines, Subunit | 1 | 2022 | 158 | 0.050 |
Why?
|
Guanosine Triphosphate | 1 | 2022 | 316 | 0.050 |
Why?
|
Exons | 2 | 2020 | 2381 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2023 | 412 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2023 | 2014 | 0.050 |
Why?
|
Cullin Proteins | 1 | 2022 | 179 | 0.050 |
Why?
|
Apoptosis | 2 | 2016 | 9476 | 0.050 |
Why?
|
Gene Frequency | 2 | 2020 | 3601 | 0.050 |
Why?
|
Calreticulin | 1 | 2022 | 114 | 0.050 |
Why?
|
beta Catenin | 1 | 2006 | 1039 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2006 | 841 | 0.050 |
Why?
|
Receptors, Virus | 1 | 2004 | 639 | 0.050 |
Why?
|
Busulfan | 1 | 2021 | 258 | 0.050 |
Why?
|
Receptors, Antigen, B-Cell | 1 | 2004 | 544 | 0.050 |
Why?
|
Perioperative Care | 1 | 2008 | 1037 | 0.040 |
Why?
|
Vidarabine | 1 | 2021 | 336 | 0.040 |
Why?
|
GATA2 Transcription Factor | 1 | 2021 | 158 | 0.040 |
Why?
|
Administration, Oral | 1 | 2008 | 4010 | 0.040 |
Why?
|
Idarubicin | 1 | 2019 | 59 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11116 | 0.040 |
Why?
|
Time Factors | 1 | 2021 | 39913 | 0.040 |
Why?
|
Molecular Biology | 1 | 2023 | 575 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2006 | 2425 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14018 | 0.040 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2023 | 678 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2022 | 870 | 0.040 |
Why?
|
Genes, Reporter | 2 | 2015 | 1525 | 0.040 |
Why?
|
Bone Marrow Cells | 2 | 2004 | 2409 | 0.040 |
Why?
|
Kinetics | 1 | 2006 | 6370 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 634 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2011 | 3548 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 99 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2023 | 1697 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2004 | 1409 | 0.040 |
Why?
|
Nuclear Pore Complex Proteins | 1 | 2019 | 163 | 0.040 |
Why?
|
Cytosine | 1 | 2019 | 211 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3777 | 0.040 |
Why?
|
Janus Kinases | 1 | 2019 | 248 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 22115 | 0.040 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12661 | 0.040 |
Why?
|
Interferon-alpha | 1 | 2022 | 902 | 0.040 |
Why?
|
K562 Cells | 1 | 2019 | 641 | 0.040 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39063 | 0.040 |
Why?
|
Frameshift Mutation | 1 | 2019 | 392 | 0.040 |
Why?
|
Granulocyte Precursor Cells | 1 | 2016 | 49 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2004 | 5463 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2016 | 465 | 0.030 |
Why?
|
Incidence | 2 | 2024 | 21337 | 0.030 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2019 | 651 | 0.030 |
Why?
|
Prospective Studies | 2 | 2023 | 54360 | 0.030 |
Why?
|
Cell Cycle | 1 | 2023 | 2930 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 2016 | 212 | 0.030 |
Why?
|
Pyridoxal Phosphate | 1 | 2015 | 121 | 0.030 |
Why?
|
Etoposide | 1 | 2016 | 634 | 0.030 |
Why?
|
Models, Molecular | 2 | 2015 | 5433 | 0.030 |
Why?
|
Genes, X-Linked | 1 | 2015 | 128 | 0.030 |
Why?
|
Reticulocytes | 1 | 2015 | 289 | 0.030 |
Why?
|
Homeostasis | 1 | 2005 | 3321 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 717 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14648 | 0.030 |
Why?
|
Pregnancy Complications, Hematologic | 1 | 2015 | 180 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2191 | 0.030 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 1 | 2015 | 179 | 0.030 |
Why?
|
Iron Overload | 1 | 2015 | 239 | 0.030 |
Why?
|
X Chromosome Inactivation | 1 | 2015 | 227 | 0.030 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2016 | 620 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 1 | 2019 | 1360 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2015 | 17629 | 0.020 |
Why?
|
Puerperal Disorders | 1 | 2015 | 300 | 0.020 |
Why?
|
GATA6 Transcription Factor | 1 | 2011 | 50 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2467 | 0.020 |
Why?
|
Megakaryocytes | 1 | 2016 | 566 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2021 | 15908 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2002 | 4341 | 0.020 |
Why?
|
Thrombosis | 1 | 2024 | 2943 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3873 | 0.020 |
Why?
|
Dendritic Cells | 1 | 2001 | 2722 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4354 | 0.020 |
Why?
|
Models, Biological | 1 | 2006 | 9461 | 0.020 |
Why?
|
Luciferases | 1 | 2011 | 712 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2016 | 1970 | 0.020 |
Why?
|
RNA, Messenger | 2 | 2015 | 12758 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2016 | 2509 | 0.020 |
Why?
|
Chromosome Aberrations | 1 | 2016 | 1768 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 64568 | 0.020 |
Why?
|
Congresses as Topic | 1 | 2014 | 802 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2413 | 0.020 |
Why?
|
Genetic Testing | 1 | 2022 | 3533 | 0.020 |
Why?
|
Mice, Inbred BALB C | 3 | 2004 | 6188 | 0.020 |
Why?
|
Cohort Studies | 2 | 2024 | 41457 | 0.020 |
Why?
|
Stroke Volume | 1 | 2023 | 5486 | 0.020 |
Why?
|
Risk Factors | 3 | 2024 | 74115 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2016 | 2189 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2006 | 11874 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3087 | 0.020 |
Why?
|
Precancerous Conditions | 1 | 2015 | 980 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3792 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2019 | 5780 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4570 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 2020 | 0.020 |
Why?
|
Protein Conformation | 1 | 2015 | 3965 | 0.020 |
Why?
|
Pedigree | 1 | 2015 | 4539 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2690 | 0.020 |
Why?
|
Immunophenotyping | 2 | 2001 | 1865 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9529 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5672 | 0.020 |
Why?
|
Mitochondrial Proteins | 2 | 2001 | 974 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2002 | 7847 | 0.020 |
Why?
|
Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2004 | 14 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2016 | 2447 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2015 | 6520 | 0.020 |
Why?
|
Neovascularization, Physiologic | 1 | 2011 | 1349 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2639 | 0.010 |
Why?
|
Immunity, Innate | 1 | 2016 | 3045 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9417 | 0.010 |
Why?
|
Mitochondria | 1 | 2016 | 3619 | 0.010 |
Why?
|
Protein Binding | 1 | 2015 | 9345 | 0.010 |
Why?
|
Cell Lineage | 2 | 2001 | 2554 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2016 | 11069 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9277 | 0.010 |
Why?
|
Receptors, Interleukin-7 | 1 | 2001 | 40 | 0.010 |
Why?
|
Bromodeoxyuridine | 1 | 2001 | 310 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2016 | 5304 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2002 | 293 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2002 | 410 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2016 | 16967 | 0.010 |
Why?
|
src-Family Kinases | 1 | 2001 | 535 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10432 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2019 | 26180 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20074 | 0.010 |
Why?
|
Age Factors | 1 | 2014 | 18381 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2002 | 990 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2001 | 1526 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18221 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2002 | 3088 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 1404 | 0.010 |
Why?
|
Up-Regulation | 1 | 2002 | 4117 | 0.010 |
Why?
|
Pregnancy | 1 | 2015 | 29868 | 0.010 |
Why?
|
Cell Line | 1 | 2004 | 15576 | 0.010 |
Why?
|
Aging | 1 | 2001 | 8699 | 0.000 |
Why?
|